Rohin Mhatre
CIK: 0001798735
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Mhatre Rohin
Mhatre Rohin (SEC CIK 0001798735) files insider reports with the SEC as Officer of Parabilis Medicines, Inc. (PBLS) and Director of REPLIGEN CORP (RGEN).
Signal8 holds 3 ownership filings by Mhatre Rohin (1 Form 3, 2 Form 4), filed between May 19, 2025 and Jun 9, 2026. Those filings report 2 transactions, from May 15, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mhatre Rohin's filings is in CAMBRIDGE, MA.
Recent filings by Mhatre Rohin
Other insiders filing for Parabilis Medicines, Inc. (PBLS)
- Tendler Craig, Director
- RA CAPITAL MANAGEMENT, L.P., Director
- Levy Guy, 10% Owner
- SEBULSKY ALAN, Director
- FITZGERALD EDWARD M, Director
- Borisy Alexis, Director